251
Participants
Start Date
February 29, 2016
Primary Completion Date
May 31, 2018
Study Completion Date
May 31, 2018
Doylestown Health Cardiology, Doylestown
Riverside Cardiology Specialists, Newport News
Duke Cardiology of Lumberton, Lumberton
Columbia Heart Clinic, PA, Columbia
Atlanta Heart Specialists, Cumming
Atlanta Institute for Medical Research, Inc., Atlanta
Holy Cross Medical Group, Coral Springs
Charlotte Heart Group, Port Charlotte
Jackson Heart Clinic, Jackson
Research Integrity, LLC., Owensboro
Cardiovascular Research of Northwest Indiana, L.L.C., Munster
Great Lakes Heart and Vascular Institute, Saint Joseph
Endeavor Medical Research, Alpena
HealthEast Medical Research Institute, Saint Paul
Ochsner Health System, New Orleans
North Texas Research Associates, Allen
Providence Health Center, Waco
Foothill Cardiology, Pasadena
Penobscot Bay Medical Center, Rockport
Cardiovascular Associates of the Delaware Valley, Elmer
Lourdes Cardiology Services, Voorhees Township
Lead Sponsor
Collaborators (2)
Bristol-Myers Squibb
INDUSTRY
Pfizer
INDUSTRY
Duke University
OTHER